ClinicalTrials.Veeva

Menu

THE PHYSIOLOGICAL EFFECTS OF ELECTROMAGNETIC EMISSIONS ON THE GENERAL CONDITION OF THE PATIENT (EPHEME)

C

Clinique Bizet

Status

Completed

Conditions

Electromagnetic Emissions and Emotional Disorder
Electromagnetic Emissions and Medication Savings

Treatments

Device: The emission of electromagnetic without the probes
Device: The emission of electromagnetic with the probes

Study type

Interventional

Funder types

Other

Identifiers

NCT04301440
2019-A03150-57

Details and patient eligibility

About

Hospital patients usually experience anxiety caused by physiological, psychological and environmental stimuli. This emotional state corresponds to the psychophysiological response to a perceived threat.

The investigator's goal is to use a non-drug approach to these problems which would help improve the quality of life of patients, prevent the consumption of anti-anxiety drugs / antidepressants; and thus to reduce the direct cost in terms of treatment, but also to reduce the indirect costs linked to work stoppages and the consumption of the care offer.

Working hypothesis: Local magnetic muscle stimulation improves people's well-being and relaxation

Full description

Primary objective :

Describe the effect of the intervention on the level of anxiety / depression in patients with anxious and / or depressive characteristics

Secondary objectives:

  • Describe the variation in the quality of life of patients before and after the intervention
  • Describe the variation in drug consumption
  • Describe the use of post intervention hospitalization
  • Describe the variation in the quality of sleep before and after the intervention
  • Describe the timeframe for returning patients to professional activity

Enrollment

37 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Major patient hospitalized for the management of a chronic pathology and / or its complications;
  • Patient with a Hospital Anxiety and Depression scale score (HAD) ≥ 8 for items assessing anxiety disorders; AND a HAD score ≥ 8 for the items assessing depressive disorders.
  • Subject affiliated to a social security scheme or beneficiary of such a scheme
  • No participation in another clinical study

Exclusion criteria

  • Minor patient
  • Pregnant and breastfeeding women
  • HAD score <8 for items evaluating anxiety disorders OR a HAD score <8 for items evaluating depressive disorders
  • Major subject protected by law, under curatorship or tutorship

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

37 participants in 2 patient groups, including a placebo group

patients with anxious and / or depressive characteristics : treated group
Active Comparator group
Description:
patients with anxious and / or depressive characteristics, The device with the electromagnetic wave will be connected
Treatment:
Device: The emission of electromagnetic with the probes
patients with anxious and / or depressive characteristics : placebo group
Placebo Comparator group
Description:
The device with the electromagnetic wave will not be connected
Treatment:
Device: The emission of electromagnetic without the probes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems